JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141413

Go 6976, PKC inhibitor

Be the first to review this product! Submit a review

|

(10 Publications)

MW 378.4 Da, Purity >99%. Potent, selective PKC inhibitor (IC50 values are 2.3 and 6.2 nM at PKCα and β1, respectively). Selectively inhibits Ca2+-dependent PKC isoforms over Ca2+-independent. No inhibitory activity at PKCδ, ε or ζ. Antitumor agent. Active in vitro and in vivo.

View Alternative Names

AAG6, Aging associated gene 6, Beta-interferon, CVID9, D14Ertd420e, FLJ35621, FLJ37491, Fibroblast interferon, IFB, IFF, IFN-beta, IFNB 1, IFNB_HUMAN, Interferon beta, Interferon beta 1 fibroblast, Interferon beta precursor, KPCA_HUMAN, KPCB_HUMAN, KPCD1_HUMAN, KPCD_HUMAN, KPCE_HUMAN, KPCG_HUMAN, KPCL_HUMAN, Kinase PKC delta, May-01, MGC 5363, MGC125656, MGC125657, MGC26269, MGC49908, MGC57564, MGC96956, NAD-dependent deacetylase sirtuin-2, NAD-dependent protein deacetylase sirtuin-2, OTTHUMP00000067291, PCKd, PKC, PKC 2, PKC MU, PKC ZETA, PKC d, PKC delta, PKC epsilon, PKC h, PKC-A, PKC-B, PKC-L, PKC-alpha, PKC-beta, PKC-gamma, PKCC, PKCE, PKCG, PKCM, PKD, PLK4_HUMAN, PRKACA, PRKC D, PRKC delta, PRKCA, PRKCB, PRKCB I, PRKCB II, PRKCB1, PRKCB2, PRKCE, PRKCG, PRKCL, PRKCM, PRKCZ, PRKD 1, Pkcea, Polo-like kinase 4, Prkch, Protein Kinase C alpha, Protein Kinase C delta, Protein kinase C, Protein kinase C alpha type, Protein kinase C beta, Protein kinase C beta type, Protein kinase C delta VIII, Protein kinase C delta type, Protein kinase C epsilon, Protein kinase C epsilon type, Protein kinase C eta, Protein kinase C eta type, Protein kinase C gamma, Protein kinase C gamma polypeptide, Protein kinase C gamma type, Protein kinase C mu, Protein kinase C mu type, Protein kinase C zeta, Protein kinase D, Protein kinase D1, Protein-serine/threonine kinase, Regulatory protein SIR2 homolog 2, SAK, SCA 14, SIR2, S. cerevisiae, homolog-loke 2, SIR2-like protein 2, SIR2L, SIR2L2, SIRT 2, SIRT2_HUMAN, STK 18, Serine/Threonine Kinase 18, Serine/threonine kinase, Serine/threonine-protein kinase 18, Serine/threonine-protein kinase D1, Serine/threonine-protein kinase PLK4, Serine/threonine-protein kinase SAK, Silencing information regulator 2 like, Silent information regulator 2, Sir2 related protein type 2, Sirtuin (silent mating type information regulation 2 homolog) 2 (S.cerevisiae), Sirtuin 2, Sirtuin type 2, Snk Akin Kinase, Tyrosine protein kinase PRKCD, aPKC, nPKC-D1, nPKC-delta, nPKC-epsilon, nPKC-eta, nPKC-mu, protein kinase C, beta 1 polypeptide, protein kinase C, beta-1

1 Images
Chemical Structure - Go 6976, PKC inhibitor (AB141413)
  • Chemical Structure

Lab

Chemical Structure - Go 6976, PKC inhibitor (AB141413)

2D chemical structure image of ab141413, Go 6976, PKC inhibitor

Key facts

CAS number

136194-77-9

Purity

>99%

Form

Solid

form

Molecular weight

378.4 Da

Molecular formula

C<sub>2</sub><sub>4</sub>H<sub>1</sub><sub>8</sub>N<sub>4</sub>O

PubChem

3501

Nature

Synthetic

Biochemical name

Go-6976

Biological description

Potent, selective PKC inhibitor (IC50 values are 2.3 and 6.2 nM at PKCα and β1, respectively). Selectively inhibits Ca2+-dependent PKC isoforms over Ca2+-independent. No inhibitory activity at PKCδ, ε or ζ. Antitumor agent. Active in vitro and in vivo.

Canonical smiles

CN1C2=CC=CC=C2C3=C4C(=C5C6=CC=CC=C6N(C5=C31)CCC#N)CNC4=O

InChi

InChI=1S/C24H18N4O/c1-27-17-9-4-2-7-14(17)20-21-16(13-26-24(21)29)19-15-8-3-5-10-18(15)28(12-6-11-25)23(19)22(20)27/h2-5,7-10H,6,12-13H2,1H3,(H,26,29)

InChiKey

VWVYILCFSYNJHF-UHFFFAOYSA-N

IUPAC Name

3-(23-methyl-14-oxo-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-3-yl)propanenitrile

Product details

This product is manufactured by BioVision, an Abcam company and was previously called 1711 Gö 6976. 1711-500 is the same size as the 500 µg size of ab141413.

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Protein kinase C (PKC) is a family of enzymes playing important roles in cell signal transduction. This family includes PKC alpha PKC delta PKC mu/PKD PKC epsilon PKC beta 1 PKC beta 2 PKC gamma PKC eta and PLK4. PKC enzymes are serine/threonine kinases with a molecular mass ranging from approximately 77 to 94 kDa. They are expressed in various tissues like brain heart and lymphocytes. These kinases respond to increased diacylglycerol (DAG) and calcium levels to become active phosphorylating multiple target proteins to modulate cellular functions.
Biological function summary

Members of the PKC family mediate many cellular processes including cell growth differentiation and apoptosis. PKC alpha delta and epsilon for example are important in signal transduction pathways involved in immune response. These kinases can function independently or as part of larger protein complexes. PKC inhibitors help study the precise biological roles of these kinases by blocking their activity in cells.

Pathways

PKC family members participate in signaling pathways like the MAPK/ERK pathway and the PI3K/Akt pathway. These pathways are important for regulating cell proliferation and survival. PKC interacts with proteins such as Ras and Raf within these signaling cascades influencing the downstream signaling that affects cellular outcomes. The balance of PKC activity impacts not only normal cellular processes but also pathological conditions.

PKC family members are linked to conditions such as cancer and cardiovascular diseases. Abnormal PKC activity can lead to uncontrolled cell proliferation in cancers or altered cardiac functions in heart disease. Specifically PKC alpha and beta are associated with tumor progression whereas PKC epsilon has connections to cardiac hypertrophy. Understanding PKC's role in these diseases has led to the development of PKC inhibitors as potential therapeutic agents targeting these kinases to alter disease progression and outcomes.

Product protocols

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Scientific reports 15:16284 PubMed40348925

2025

STAT3-mediated upregulation of TRIM6 promotes hepatocellular carcinoma invasion through the DDX58-Snail1 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Yiqiao Wang,Jie Wang,Shihao Huang,Xingjing Liu,Yangbai Cai,Taicheng Wang,Hongyan Zhao,Xianke Lin,Xueguo Wang,Peng Li

Cell biology and toxicology 40:90 PubMed39433604

2024

G-CSFR-induced leukocyte transendothelial migration during the inflammatory response is regulated by the ICAM1-PKCa axis: based on multiomics integration analysis.

Applications

Unspecified application

Species

Unspecified reactive species

Zhipeng Zhu,Xiaoyan Ling,Gaojian Wang,Junran Xie

Journal of neurochemistry 161:478-491 PubMed35583089

2022

Signaling pathways involved in NMDA-induced suppression of M-channels in corticotropin-releasing hormone neurons in central amygdala.

Applications

Unspecified application

Species

Unspecified reactive species

Hua Zhang,Zhao-Fu Sheng,Jingxiong Wang,PeiRu Zheng,XunLei Kang,Hui-Ming Chang,Edward T H Yeh,De-Pei Li

American journal of physiology. Cell physiology 321:C355-C368 PubMed34133238

2021

A rapid degradation of calponin 2 is required for cytokinesis.

Applications

Unspecified application

Species

Unspecified reactive species

Airong Qian,Tzu-Bou Hsieh,M Moazzem Hossain,Jim J-C Lin,J-P Jin

Journal of neuroinflammation 16:36 PubMed30760300

2019

Therapeutic hypercapnia reduces blood-brain barrier damage possibly via protein kinase Cε in rats with lateral fluid percussion injury.

Applications

Unspecified application

Species

Unspecified reactive species

Wan-Chao Yang,Qi Wang,Lai-Ting Chi,Yue-Zhen Wang,Hong-Ling Cao,Wen-Zhi Li

The Journal of biological chemistry 294:887-901 PubMed30463939

2018

Inhibition of ezrin causes PKCα-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jaekwang Jeong,Jungmin Choi,Wonnam Kim,Pamela Dann,Farzin Takyar,Julia V Gefter,Peter A Friedman,John J Wysolmerski

The Journal of biological chemistry 293:11119-11130 PubMed29794026

2018

Protein kinase Cα drives fibroblast activation and kidney fibrosis by stimulating autophagic flux.

Applications

Unspecified application

Species

Unspecified reactive species

Xian Xue,Jiafa Ren,Xiaoli Sun,Yuan Gui,Ye Feng,Bingyan Shu,Wei Wei,Qingmiao Lu,Yan Liang,Weichun He,Junwei Yang,Chunsun Dai

The Journal of pathology 242:488-499 PubMed28585302

2017

Rictor/mammalian target of rapamycin complex 2 promotes macrophage activation and kidney fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Jiafa Ren,Jianzhong Li,Ye Feng,Bingyan Shu,Yuan Gui,Wei Wei,Weichun He,Junwei Yang,Chunsun Dai

Journal of leukocyte biology 101:683-692 PubMed28250113

2017

CXCL12-induced macropinocytosis modulates two distinct pathways to activate mTORC1 in macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Regina Pacitto,Isabella Gaeta,Joel A Swanson,Sei Yoshida

Pain 157:1541-1550 PubMed26963850

2016

Epac-protein kinase C alpha signaling in purinergic P2X3R-mediated hyperalgesia after inflammation.

Applications

Unspecified application

Species

Unspecified reactive species

Yanping Gu,Guangwen Li,Yong Chen,Li-Yen Mae Huang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com